| 摘要 |
<p>The invention relates to an in vitro method for detecting the activation of NADPH oxidase by measuring gp91phox protein levels in biological fluids, as a marker of oxidative stress. The method is useful for testing the oxidative stress levels in dysmetabolic pathologies, such as diabetes, hypercholesterolemia and hyperlipidemia, in pathologies of the cardiovascular district, such as hypertension, atherosclerosis, cardiac hypertophy and stroke, and in clinical conditions comprising sepsis and diseases with a strong inflammatory component.</p> |
